Evidence map›Paper›PMID 27599135›Full record

ArticleThe Lancet. Oncology2016

Do cancer survival statistics for every hospital make sense?

Melanie Morris, Manuela Quaresma, Janne Pitkäniemi, Eva Morris, Bernard Rachet, Michel P Coleman

Abstract read
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Melanie MorrisCancer Research UK Cancer Survival Group, Faculty of Epidemiology and Population Health, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK. Electronic address: melanie.morris@lshtm.ac.uk.
Manuela QuaresmaCancer Research UK Cancer Survival Group, Faculty of Epidemiology and Population Health, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.
Janne PitkäniemiFinnish Cancer Registry, Unioninkatu 22, FI-00130 Helsinki, Finland.
Eva MorrisSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
Bernard RachetCancer Research UK Cancer Survival Group, Faculty of Epidemiology and Population Health, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.
Michel P ColemanCancer Research UK Cancer Survival Group, Faculty of Epidemiology and Population Health, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.

Funding

Cancer Research UK 11700Cancer Research UK 18348Cancer Research UK 18525Cancer Research UK C7923/A18348Cancer Research UK C7923/A18525Medical Research Council MR/L01629X/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Data AccuracyDisease-Free SurvivalHospital MortalityHospitalsHumansNeoplasmsOncology Service, HospitalPatient ReadmissionProcess Assessment, Health CareQuality Indicators, Health CareRisk FactorsTime FactorsTreatment Outcome

Identifiers

PMID27599135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.